Clinical TrialsSearch results
Number of results: 232
Other
- An open-label, randomized, controlled trial comparing different dosing regimens with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C.
- Chronic hepatitis C with serogroup 1 and high viral load (>= 100 KIU/mL).
- Okayama University Hospital
- 2008-02-29
Other
- Open-label, randomized, controlled study evaluating dose-escalation of peginterferon alpa-2b plus ribavirin in aged patients with chronic hepatitis C
- Chronic hepatitis C
- Okayama University Hospital
- 2014-10-01
Other
- Open-label, randomized, controlled study peginterferon alpa-2b plus dose-escalation of ribavirin in patients with chronic hepatitis C
- Chronic hepatitis C
- Okayama University Hospital
- 2014-10-01
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Randomized comparative study of cisplatin, docetaxel, and irinotecan versus cisplatin and docetaxel in patients with stage IIIB or stage IV non-small cell lung cancer (OLCSG 0403)
- Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-13
Other
- Randomized, comparative clinical study of cisplatin and docetaxel combination chemotherapy and mitomycin, vindesine and cisplatin (MVP) combination chemotherapy with concurrent thoracic radiation therapy for locally advanced unresectable non-small-cell lung cancer (OLCSG0007)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group (OLCSG)
- 2005-09-12
Other
- Phase I study of S-1 with concurrent thoracic radiation therapy for elderly inoperable locally advanced non-small-cell lung cancer
- Elderly inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase I/II study of cisplatin and S-1 with concurrent thoracic radiation therapy for inoperable locally advanced non-small-cell lung cancer (OLCSG 0501)
- inoperable locally advanced non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of cisplatin, docetaxel, and irinotecan, followed by gefitinib, gemcitabine and vinorelbine for patients with non-small-cell lung cancer harboring active EGFR gene mutations (OLCSG0704)
- non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2009-08-01
Other
- Phase II study of erlotinib monotherapy for relapsed patients with non-small-cell lung cancer who do not possess any active EGFR gene mutations
- relapsed non-small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2008-11-16